Enoxaparin Monograph: Anticoagulant Mechanism, Dosing, Renal Adjustment and Safety

Evidence-informed medical pharmacology article updated 10 November 2026. For education; prescribing requires current local labeling and individual patient assessment. Overview and clinical role Enoxaparin is a low-molecular-weight heparin (LMWH) used to prevent and treat venous thromboembolism and in selected acute coronary syndrome regimens. It is an anticoagulant, not a thrombolytic, and does not directly dissolve…

Read Full News

Ezetimibe Monograph: NPC1L1 Inhibition, LDL Reduction and Cardiovascular Use

Evidence-informed medical pharmacology article updated 10 November 2026. For education; prescribing requires current local labeling and individual patient assessment. Overview Ezetimibe is a nonstatin LDL-cholesterol-lowering agent that blocks intestinal cholesterol uptake. It can be used as an adjunct to statins when LDL-C goals are not achieved, and as an alternative or component of treatment when…

Read Full News

Fenofibrate Monograph: PPAR-Alpha, Triglycerides, Kidney Dosing and Safety

Evidence-informed medical pharmacology article updated 10 November 2026. For education; prescribing requires current local labeling and individual patient assessment. Overview Fenofibrate is a fibrate lipid-modifying medicine used principally to lower elevated triglycerides. Its triglyceride-lowering effect does not mean it reliably adds cardiovascular event reduction when prescribed to every statin-treated patient. Treat secondary causes, dietary factors,…

Read Full News

Rosuvastatin Monograph: LDL Lowering, 2026 Dosing Guidance and Interactions

Evidence-informed medical pharmacology article updated 10 November 2026. For education; prescribing requires current local labeling and individual patient assessment. Overview Rosuvastatin is a potent, relatively hydrophilic synthetic statin that inhibits hepatic HMG-CoA reductase, increasing LDL-receptor activity and lowering LDL cholesterol. It is used to reduce ASCVD risk in appropriately selected patients and to treat primary…

Read Full News

Simvastatin Monograph: HMG-CoA Reductase, CYP3A4 Interactions and 80-mg Restriction

Evidence-informed medical pharmacology article updated 10 November 2026. For education; prescribing requires current local labeling and individual patient assessment. Overview Simvastatin is a lipophilic, lactone-prodrug statin used to lower LDL cholesterol and prevent ASCVD in selected patients. Its strong CYP3A4 interaction liability and myopathy risk at higher doses have made alternative statins preferable when high-intensity…

Read Full News

Adenosine Monograph: Receptor Pharmacology, SVT Termination and Critical Precautions

Evidence-informed pharmacology monograph, updated 10 November 2026. For medical education; individual management requires current product labeling and qualified clinical assessment. Clinical overview Adenosine is an endogenous purine nucleoside and a very short-acting intravenous antiarrhythmic that transiently suppresses AV-node conduction. It is most useful for terminating specific regular AV-node-dependent supraventricular tachycardias (SVTs); its coronary vasodilator action…

Read Full News

Sotalol Monograph: Class II/III Antiarrhythmic Effects, QT Monitoring and Renal Dosing

Evidence-informed pharmacology monograph, updated 10 November 2026. For medical education; individual management requires current product labeling and qualified clinical assessment. Overview Sotalol is a nonselective beta-adrenoceptor antagonist with class III antiarrhythmic effects due to inhibition of the rapid delayed rectifier potassium current (IKr). It can suppress selected serious ventricular arrhythmias and maintain sinus rhythm in…

Read Full News

Quinidine Monograph: Class IA Antiarrhythmic Mechanism, Torsades and Interactions

Evidence-informed pharmacology monograph, updated 10 November 2026. For medical education; individual management requires current product labeling and qualified clinical assessment. Overview Quinidine is a cinchona alkaloid and class IA antiarrhythmic with sodium-channel blocking and repolarization-prolonging effects. Although historically used for atrial and ventricular arrhythmias, its use today is limited by torsades de pointes, adverse effects…

Read Full News

Procainamide Monograph: Class IA Pharmacology, NAPA, IV Safety and Drug-Induced Lupus

Evidence-informed pharmacology monograph, updated 10 November 2026. For medical education; individual management requires current product labeling and qualified clinical assessment. Overview and chemistry Procainamide is a class IA antiarrhythmic used in selected monitored settings for atrial or ventricular tachyarrhythmias. It is p-amino-N-[2-(diethylamino)ethyl]benzamide, structurally related to but distinct from the ester local anesthetic procaine. The former…

Read Full News

Isosorbide Dinitrate Monograph: NO–cGMP Vasodilation, Angina and HFrEF Combination

Evidence-informed pharmacology monograph, updated 10 November 2026. For medical education; individual management requires current product labeling and qualified clinical assessment. Overview and chemistry Isosorbide dinitrate (ISDN) is an organic nitrate ester used for prevention of angina and, in combination with hydralazine, selected heart-failure indications. Its correct molecular formula is C6H8N2O8, not C6H10O8. Oral immediate-release ISDN…

Read Full News